The effect of intermittent parathyroid hormone on bone lengthening: current evidence to inform future effective interventions Nitchanant KitcharanantNipon ChattipakornSiriporn C Chattipakorn Review 08 June 2023 Pages: 1657 - 1675
Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects Abolfazl BagherifardAzam HosseinzadehSaeed Mehrzadi Review 02 July 2023 Pages: 1677 - 1701
Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study Hiroshi HaginoKenta MoriwakiHiromi Matsumoto Original Article 08 June 2023 Pages: 1703 - 1709
Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise Zoe PaskinsAlice MoultOpinder Sahota Original Article 09 June 2023 Pages: 1711 - 1718
Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population Guiwu HuangXiong ChenGang Zeng Original Article Open access 12 June 2023 Pages: 1719 - 1727
Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan Fang-Chun LiuKwing-Chi LukYung-Chih Chen Original Article Open access 16 June 2023 Pages: 1729 - 1737
Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study N.R. GadgaardC. VarnumA.B. Pedersen Original Article Open access 17 June 2023 Pages: 1739 - 1749
Impact of fragility fractures on activities of daily living and productivity in community-dwelling women: a multi-national study Eric J. YehOlivera Rajkovic-HooleyAlireza Moayyeri Original Article Open access 19 June 2023 Pages: 1751 - 1762
Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry X. ZhangM. YangM. Tian Original Article 21 June 2023 Pages: 1763 - 1770
Drug utilization analysis of osteoporosis medications in seven European electronic health databases Eng Hooi TanDanielle E. RobinsonMaria T. Sanchez-Santos Original Article Open access 12 July 2023 Pages: 1771 - 1781
Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients Yi-Lun TsaiChih-Hsing WuTa-Wei Tai Original Article 19 July 2023 Pages: 1783 - 1791
Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture John T. SchousboeNeil BinkleyWilliam D. Leslie Short Communication 28 June 2023 Pages: 1793 - 1798
Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS) Ángel Oteo-ÁlvaroCarlos Goicoechea GarcíaJavier de Diego-Adeliño Case Report 05 July 2023 Pages: 1799 - 1804
Gender differences in osteoporosis Carolina MazedaAnabela Barcelos Letter to the Editor 20 July 2023 Pages: 1805 - 1806
Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases D. FitzpatrickS. SeebahK. Mc Carroll Letter to the Editor 01 August 2023 Pages: 1807 - 1808
Author response to OSIN-D-23–00510, “Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?” Takumi Hasegawa Letter to the Editor 07 July 2023 Pages: 1809 - 1809
Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Efsun Somay Letter to the Editor 07 July 2023 Pages: 1811 - 1812
Author response to: Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study Mohamed AbdalbaryAmr El-Husseini Letter to the Editor 14 August 2023 Pages: 1813 - 1813
Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study. Osteoporos Int. 2023 Apr;34(4):763–774 Maria João Martins Letter to the Editor 14 August 2023 Pages: 1815 - 1816
The importance of structural barriers of osteoporotic hip fracture in the elderly H. MeijideI. GredillaI. Susperregui Letter to the Editor 14 August 2023 Pages: 1817 - 1818
Response letter to: “The importance of structural barriers of osteoporotic hip fracture in the elderly” Ruqayyah Yahya TurabiKatie Jane Sheehan Letter to the Editor 14 August 2023 Pages: 1819 - 1819
A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy) Eiman Shahrour Letter to the Editor 30 August 2023 Pages: 1821 - 1822
Correction to: Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study T. HasegawaN. UedaJapanese Study Group of Co-operative Dentistry with Medicine (JCDM) Correction 26 July 2023 Pages: 1823 - 1825
